CTHRC1 and ovarian carcinoma: Additionally, miR-30b-3p, downregulated in ovarian cancer R3 cells, suppresses proliferation, promotes apoptosis, slows cell cycle progression, and inhibits migration and invasion upon overexpression; it directly targets CTHRC1, thereby linking it to EMT and suggesting its potential as a biomarker and therapeutic candidate (88).